Matches in SemOpenAlex for { <https://semopenalex.org/work/W2887191509> ?p ?o ?g. }
- W2887191509 endingPage "65" @default.
- W2887191509 startingPage "55" @default.
- W2887191509 abstract "The HIV-1 transactivator of transcription (Tat) is a neurotoxin involved in the pathogenesis of HIV-1 associated neurocognitive disorders (HAND). The neurotoxic effects of Tat are mediated directly via AMPA/NMDA receptor activity and indirectly through neuroinflammatory signaling in glia. Emerging strategies in the development of neuroprotective agents involve the modulation of the endocannabinoid system. A major endocannabinoid, anandamide (N-arachidonoylethanolamine, AEA), is metabolized by fatty acid amide hydrolase (FAAH). Here we demonstrate using a murine prefrontal cortex primary culture model that the inhibition of FAAH, using PF3845, attenuates Tat-mediated increases in intracellular calcium, neuronal death, and dendritic degeneration via cannabinoid receptors (CB1R and CB2R). Live cell imaging was used to assess Tat-mediated increases in [Ca2+]i, which was significantly reduced by PF3845. A time-lapse assay revealed that Tat potentiates cell death while PF3845 blocks this effect. Additionally PF3845 blocked the Tat-mediated increase in activated caspase-3 (apoptotic marker) positive neurons. Dendritic degeneration was characterized by analyzing stained dendritic processes using Imaris and Tat was found to significantly decrease the size of processes while PF3845 inhibited this effect. Incubation with CB1R and CB2R antagonists (SR141716A and AM630) revealed that PF3845-mediated calcium effects were dependent on CB1R, while reduced neuronal death and degeneration was CB2R-mediated. PF3845 application led to increased levels of AEA, suggesting the observed effects are likely a result of increased endocannabinoid signaling at CB1R/CB2R. Our findings suggest that modulation of the endogenous cannabinoid system through inhibition of FAAH may be beneficial in treatment of HAND." @default.
- W2887191509 created "2018-08-22" @default.
- W2887191509 creator A5002256644 @default.
- W2887191509 creator A5004807635 @default.
- W2887191509 creator A5010070535 @default.
- W2887191509 creator A5022995099 @default.
- W2887191509 creator A5025755881 @default.
- W2887191509 creator A5030544754 @default.
- W2887191509 creator A5054637908 @default.
- W2887191509 creator A5055631023 @default.
- W2887191509 creator A5063529758 @default.
- W2887191509 date "2018-10-01" @default.
- W2887191509 modified "2023-10-18" @default.
- W2887191509 title "Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS" @default.
- W2887191509 cites W1500005891 @default.
- W2887191509 cites W1548409859 @default.
- W2887191509 cites W1581091695 @default.
- W2887191509 cites W1604823664 @default.
- W2887191509 cites W1789490659 @default.
- W2887191509 cites W1968772660 @default.
- W2887191509 cites W1974835419 @default.
- W2887191509 cites W1976434061 @default.
- W2887191509 cites W1978155055 @default.
- W2887191509 cites W1979657613 @default.
- W2887191509 cites W1982946237 @default.
- W2887191509 cites W1993264471 @default.
- W2887191509 cites W1995746794 @default.
- W2887191509 cites W1998688963 @default.
- W2887191509 cites W1998934835 @default.
- W2887191509 cites W2001088431 @default.
- W2887191509 cites W2002355116 @default.
- W2887191509 cites W2003545714 @default.
- W2887191509 cites W2005194978 @default.
- W2887191509 cites W2006733828 @default.
- W2887191509 cites W2010358244 @default.
- W2887191509 cites W2019288170 @default.
- W2887191509 cites W2026350942 @default.
- W2887191509 cites W2029843028 @default.
- W2887191509 cites W2031297664 @default.
- W2887191509 cites W2037803861 @default.
- W2887191509 cites W2038183008 @default.
- W2887191509 cites W2040580317 @default.
- W2887191509 cites W2042441113 @default.
- W2887191509 cites W2048638801 @default.
- W2887191509 cites W2052769426 @default.
- W2887191509 cites W2057794545 @default.
- W2887191509 cites W2059223813 @default.
- W2887191509 cites W2060064384 @default.
- W2887191509 cites W2062526841 @default.
- W2887191509 cites W2064128689 @default.
- W2887191509 cites W2066487397 @default.
- W2887191509 cites W2068252252 @default.
- W2887191509 cites W2070357113 @default.
- W2887191509 cites W2080276255 @default.
- W2887191509 cites W2082711927 @default.
- W2887191509 cites W2088979187 @default.
- W2887191509 cites W2089300574 @default.
- W2887191509 cites W2089431194 @default.
- W2887191509 cites W2091284200 @default.
- W2887191509 cites W2092535327 @default.
- W2887191509 cites W2095083924 @default.
- W2887191509 cites W2103915735 @default.
- W2887191509 cites W2109169003 @default.
- W2887191509 cites W2109343684 @default.
- W2887191509 cites W2113466274 @default.
- W2887191509 cites W2119693765 @default.
- W2887191509 cites W2128044935 @default.
- W2887191509 cites W2130599091 @default.
- W2887191509 cites W2130693267 @default.
- W2887191509 cites W2130841069 @default.
- W2887191509 cites W2133702956 @default.
- W2887191509 cites W2135520652 @default.
- W2887191509 cites W2136160086 @default.
- W2887191509 cites W2138294676 @default.
- W2887191509 cites W2141260882 @default.
- W2887191509 cites W2146347032 @default.
- W2887191509 cites W2155840309 @default.
- W2887191509 cites W2162441137 @default.
- W2887191509 cites W2163150813 @default.
- W2887191509 cites W2187648708 @default.
- W2887191509 cites W2301601305 @default.
- W2887191509 cites W2402821959 @default.
- W2887191509 cites W2565538373 @default.
- W2887191509 cites W2600015680 @default.
- W2887191509 cites W2620640092 @default.
- W2887191509 cites W2738228275 @default.
- W2887191509 cites W2753450652 @default.
- W2887191509 doi "https://doi.org/10.1016/j.neuropharm.2018.08.013" @default.
- W2887191509 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6296377" @default.
- W2887191509 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30114402" @default.
- W2887191509 hasPublicationYear "2018" @default.
- W2887191509 type Work @default.
- W2887191509 sameAs 2887191509 @default.
- W2887191509 citedByCount "23" @default.
- W2887191509 countsByYear W28871915092019 @default.
- W2887191509 countsByYear W28871915092020 @default.
- W2887191509 countsByYear W28871915092021 @default.
- W2887191509 countsByYear W28871915092022 @default.